Sanofi Settles Insulin Pen Antitrust Suit, Avoiding Trial
Sanofi-Aventis US and a group of drug wholesalers have told a Massachusetts federal judge they have reached a settlement to resolve long-running antitrust litigation alleging that the drugmaker improperly sought to...To view the full article, register now.
Already a subscriber? Click here to view full article